Cobiprostone

DRUG3 trials

Sponsors

Sucampo Pharma Americas, LLC

Conditions

NSAID-induced Gastroduodenal InjuryOral MucositisOsteoarthritisPortal HypertensionRheumatoid ArthritisUlcers

Phase 2

Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury

CompletedNCT00597818

Sucampo Pharma Americas, LLCNSAID-induced Gastroduodenal Injury, Osteoarthritis, Rheumatoid Arthritis +1

Start: 2007-08-31End: 2009-05-31Updated: 2019-12-26

Efficacy and Safety of Cobiprostone in Patients With Portal Hypertension

TerminatedNCT00737594

Sucampo Pharma Americas, LLCPortal Hypertension

Start: 2008-07-31End: 2009-03-31Updated: 2019-11-18

Cobiprostone for the Prevention of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concurrent Radiation and Chemotherapy

TerminatedNCT02542215

Sucampo Pharma Americas, LLCOral Mucositis

Start: 2015-06-30End: 2016-07-31Updated: 2019-12-02